Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Side Effects to be Discovered more Quickly, Leading to Safer Prescribing

Published: Monday, April 15, 2013
Last Updated: Monday, April 15, 2013
Bookmark and Share
BMJ Learning has teamed up with the MHRA to launch a new, interactive and multimedia learning module on pharmacovigilance.

The module will support healthcare professionals know how and when to report side effects of medications – an essential element of patient safety.

Drug side effects are a major public health concern worldwide and are amongst the leading cause of death in many countries. Although no medicine is ever completely free of risk, the World Health Organization estimates that at least 60% of adverse drug reactions are preventable.

Effective reporting of drug reactions is an important way for healthcare professionals to contribute to the safer use of medicines. In the UK, this is done by completing a Yellow Card and submitting it to the MHRA. This is a quick and easy process, and can be done online or by post.

Although this Yellow Card scheme provides valuable information, its effectiveness is limited by under-reporting. Busy healthcare workers may mistakenly assume that reporting is a time consuming and complicated process, or that the information they have is not useful.

This module will help to change that view. After completing the module, healthcare professionals will understand the importance of continuous monitoring for adverse drug effects, know which type of situation should trigger a report through the Yellow Card scheme, and be able to fill out a Yellow Card correctly.

They should also know where to find up-to-date information on adverse effects of drugs, and be able to use that information to make safe prescribing choices.

One doctor who completed the module said: "Interesting and very relevant. Will encourage me to adverse report more often.” Another commented: “Very simple to follow. Good videos. Useful - will pay more attention to yellow cards from now on."

Dr June Raine, Director of Vigilance and Risk Management of Medicines at the MHRA said: "The education module that has been developed has been written for healthcare professionals who routinely make decisions about prescribing, supplying or administering medicines. We hope it provides a useful tool in professional development and increasing understanding of the role of healthcare professionals in contributing to the knowledge and understanding of the risks and side-effects of medicines. This in turn should help in making treatment choices with patients."

Dr Kieran Walsh, Clinical Director of BMJ Learning, said: "Adverse side effects to new or old drugs happen all the time, but they are not reported as often as they should be to the correct authorities. This module explains to all healthcare professionals how to do this. It is an important guide to help everyone improve their performance in this essential component of patient safety."

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

MHRA Appoints New Chief Executive
The Medicines and Healthcare Products Regulatory Agency (MHRA) announced the appointment of Dr Ian Hudson as its Chief Executive.
Friday, July 05, 2013
MHRA Prioritises Science and Research Support as Part of New Corporate Plan
MHRA announced its aim to be a leading regulator on the world stage in supporting science and research as part of its new five-year corporate plan.
Monday, April 15, 2013
The Medicines Act Hits 40
The 25th October 2008 will mark the 40th birthday of the Medicines Act. For the past 40 years, the Act has served as the corner-stone of domestic medicines regulation, safe guarding public health.
Friday, October 24, 2008
New Web Resource About Medicines
From today, people can access a new authoritative source of information on the Internet about medicines.
Friday, September 26, 2008
British Pharmacopoeia Launches New Website
The Medicines and Healthcare products Regulatory Agency (MHRA) has today launched the new British Pharmacopoeia (BP) website
Tuesday, September 09, 2008
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Gut Microbes Signal to the Brain When They're Full
Don't have room for dessert? The bacteria in your gut may be telling you something.
Personalized Drug Screening for Multiple Myeloma Patients
A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Cancer-Fighting Tomato Component Traced
The metabolic pathway associated with lycopene, the bioactive red pigment found in tomatoes, has been traced by researchers at the University of Illinois.
Batten Disease may Benefit from Gene Therapy
NIH-funded animal study suggests one-shot approach to injecting genes.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Molecule Proves Key to Brain Repair After Stroke
Scientists found that a molecule known as growth and differentiation factor 10 (GDF10) plays a key role in repair mechanisms following stroke.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos